SNCA and glycogen storage disease VI: Recently we proposed a research biological definition and staging system for neuronal α-synuclein disease (NSD-ISS)(10), with NSD defined by the presence of biomarker of pathological neuronal α-synuclein species as the primary biological anchor, and dopaminergic neuronal dysfunction as a subsequent additional biological anchor.